Article Versions Notes

Saar M, Jaal J, Meltsov A, Laasfeld T, Lust H, Kasvandik S, Lavogina D. Exploring the Molecular Players behind the Potentiation of Chemotherapy Effects by Durvalumab in Lung Adenocarcinoma Cell Lines. Pharmaceutics. 2023; 15(5):1485. https://doi.org/10.3390/pharmaceutics15051485

Saar, Marika, Jana Jaal, Alvin Meltsov, Tõnis Laasfeld, Helen Lust, Sergo Kasvandik, and Darja Lavogina. 2023. "Exploring the Molecular Players behind the Potentiation of Chemotherapy Effects by Durvalumab in Lung Adenocarcinoma Cell Lines" Pharmaceutics 15, no. 5: 1485. https://doi.org/10.3390/pharmaceutics15051485

Saar, M., Jaal, J., Meltsov, A., Laasfeld, T., Lust, H., Kasvandik, S., & Lavogina, D. (2023). Exploring the Molecular Players behind the Potentiation of Chemotherapy Effects by Durvalumab in Lung Adenocarcinoma Cell Lines. Pharmaceutics, 15(5), 1485. https://doi.org/10.3390/pharmaceutics15051485